Richard L. Theriault

Once daily, oral, outpatient quinolone monotherapy for low‐risk cancer patients with fever and neutropenia

R. Theriault, R. Benjamin, L. Elting, 2006, Cancer.

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy

G. Hortobagyi, V. Valero, D. Booser, 2000, Cancer.

Results and long term follow‐up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin‐containing chemotherapy

Terry L. Smith, G. Hortobagyi, R. Theriault, 1999, Cancer.

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center

G. Hortobagyi, S. Singletary, F. Ames, 1997, Cancer Chemotherapy and Pharmacology.

Inflammatory carcinoma of the breast: results of a combined-modality approach — M. D. Anderson Cancer Center experience

G. Hortobagyi, S. Singletary, F. Ames, 1990, Cancer Chemotherapy and Pharmacology.

Capecitabine for 5‐Fluorouracil‐Resistant Brain Metastases From Breast Cancer

Michael L. Wang, W. Yung, R. Theriault, 2001, American journal of clinical oncology.

Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ

Wei Jiang, J. Niland, S. Edge, 2012, Cancer.